Johan Bjerner

986 total citations
30 papers, 681 citations indexed

About

Johan Bjerner is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Johan Bjerner has authored 30 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Johan Bjerner's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Advanced Biosensing Techniques and Applications (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Johan Bjerner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Advanced Biosensing Techniques and Applications (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Johan Bjerner collaborates with scholars based in Norway, United States and Sweden. Johan Bjerner's co-authors include Kjell Nustad, Ole P. Børmer, Nils Bolstad, Trine Bjøro, Lars F. Norum, Elisabeth Paus, David J. Warren, Hege Sagstuen Haugnes, Mette Sprauten and Milada Cvancarova and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Johan Bjerner

29 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Bjerner Norway 15 195 148 146 141 111 30 681
Julia Gallwas Germany 20 201 1.0× 113 0.8× 433 3.0× 93 0.7× 179 1.6× 77 1.2k
MW Beckmann Germany 18 156 0.8× 220 1.5× 130 0.9× 61 0.4× 272 2.5× 133 1.1k
Anne Fajac France 17 274 1.4× 55 0.4× 80 0.5× 38 0.3× 257 2.3× 40 834
Iordanis Navrozoglou Greece 15 98 0.5× 219 1.5× 116 0.8× 41 0.3× 200 1.8× 49 861
Radek Kučera Czechia 19 281 1.4× 111 0.8× 94 0.6× 60 0.4× 309 2.8× 94 1.0k
Elena Del Ferro Italy 14 83 0.4× 199 1.3× 87 0.6× 35 0.2× 277 2.5× 22 794
Anna Sieńko United States 19 163 0.8× 110 0.7× 147 1.0× 38 0.3× 141 1.3× 32 770
G.L. Andriole United States 12 250 1.3× 76 0.5× 270 1.8× 39 0.3× 87 0.8× 30 867
David J. Benjamin United States 14 133 0.7× 101 0.7× 182 1.2× 52 0.4× 130 1.2× 77 647
Shiyou Wei China 18 255 1.3× 71 0.5× 169 1.2× 33 0.2× 158 1.4× 53 921

Countries citing papers authored by Johan Bjerner

Since Specialization
Citations

This map shows the geographic impact of Johan Bjerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Bjerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Bjerner more than expected).

Fields of papers citing papers by Johan Bjerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Bjerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Bjerner. The network helps show where Johan Bjerner may publish in the future.

Co-authorship network of co-authors of Johan Bjerner

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Bjerner. A scholar is included among the top collaborators of Johan Bjerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Bjerner. Johan Bjerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Куклин, В. Н., Mikhail A. Sovershaev, Johan Bjerner, et al.. (2024). Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis. Critical Care. 28(1). 12–12. 14 indexed citations
2.
Bjerner, Johan, Ola Bratt, Peter C. Albertsen, et al.. (2023). Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium. European Urology. 86(1). 20–26. 4 indexed citations
3.
4.
Bjøro, Trine, Elisabeth Paus, Johan Bjerner, et al.. (2017). Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors. Clinical Biochemistry. 52. 73–79. 6 indexed citations
5.
Sprauten, Mette, Hege Sagstuen Haugnes, Marianne Brydøy, et al.. (2015). Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors. Annals of Oncology. 26(10). 2133–2140. 47 indexed citations
6.
7.
Bolstad, Nils, et al.. (2011). Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera. Clinical Chemistry and Laboratory Medicine (CCLM). 49(12). 2001–6. 32 indexed citations
8.
Bolstad, Nils, et al.. (2011). Human epididymis protein 4 reference limits and natural variation in a Nordic reference population. Tumor Biology. 33(1). 141–148. 87 indexed citations
9.
Reinton, Nils, Harald Moi, Johan Bjerner, & Amir Moghaddam. (2010). Den svenske chlamydiavarianten nvC trachomatis i Norge. Tidsskrift for Den norske legeforening. 130(4). 380–381. 4 indexed citations
10.
Bjerner, Johan, et al.. (2009). Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project. Scandinavian Journal of Clinical and Laboratory Investigation. 69(8). 873–879. 30 indexed citations
11.
Warren, David J., et al.. (2008). Automated Time-Resolved Immunofluorometric Assay for Progastrin-Releasing Peptide. Clinical Chemistry. 54(5). 919–922. 19 indexed citations
12.
Bjerner, Johan, et al.. (2008). Progastrin-Releasing Peptide: Stability in Plasma/Serum and Upper Reference Limit. Tumor Biology. 29(3). 204–210. 21 indexed citations
13.
Bjerner, Johan, et al.. (2008). Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa‐foeto‐protein (AFP), neuron‐specific enolase (NSE) and CA19.9 from the NORIP study. Scandinavian Journal of Clinical and Laboratory Investigation. 68(8). 703–713. 36 indexed citations
14.
Bjerner, Johan. (2005). Human anti‐immunoglobulin antibodies interfering in immunometric assays. Scandinavian Journal of Clinical and Laboratory Investigation. 65(5). 349–364. 18 indexed citations
15.
Warren, David J., Johan Bjerner, Elisabeth Paus, Ole P. Børmer, & Kjell Nustad. (2005). Use of an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic Antibodies. Clinical Chemistry. 51(5). 830–838. 40 indexed citations
16.
Bjerner, Johan, et al.. (2005). Human heterophilic antibodies display specificity for murine IgG subclasses. Clinical Biochemistry. 38(5). 465–472. 22 indexed citations
17.
Bjerner, Johan, et al.. (2004). Testing and validating a homogeneous immunometric assay for interference. Clinical Chemistry and Laboratory Medicine (CCLM). 42(2). 208–14. 7 indexed citations
18.
19.
Bjerner, Johan, et al.. (2002). Protein Epitopes in Carcinoembryonic Antigen. Tumor Biology. 23(4). 249–262. 29 indexed citations
20.
Bjerner, Johan, Lars F. Norum, Olle Nilsson, & Kjell Nustad. (2002). MUC1 Serum Assays in Breast Cancer: Tumor Specificities and Reference Levels. Tumor Biology. 23(6). 315–323. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Gallwas Breakdown of academic impact, for papers by MW Beckmann Breakdown of academic impact, for papers by Anne Fajac Breakdown of academic impact, for papers by Iordanis Navrozoglou Breakdown of academic impact, for papers by Radek Kučera Breakdown of academic impact, for papers by Elena Del Ferro Breakdown of academic impact, for papers by Anna Sieńko Breakdown of academic impact, for papers by G.L. Andriole Breakdown of academic impact, for papers by David J. Benjamin Breakdown of academic impact, for papers by Shiyou Wei
Rankless by CCL
2026